FDA OKs Voluven for post-op blood loss

Dec 28, 2007

The U.S. Food and Drug Administration has approved Voluven as a treatment for blood loss after surgery.

Voluven is an intravenous solution that expands blood volume, the agency said Thursday in a release.

Significant blood loss can cause a rapid drop in the volume of red blood cells and plasma circulating through the body. This can lead to shock, which is potentially fatal.

Blood volume expanders are commonly administered to restore quickly some of the lost volume so remaining red blood cells can continue to deliver needed oxygen to the body's tissues, the FDA said.

Voluven, made by the German-firm Fresenius Kabi, contains a synthetic starch that does not dissolve in water. It was found in clinical trials to be as safe and effective as other blood volume expanders, the agency said.

The most common side effects from Voluven were nausea and itching.

Copyright 2007 by United Press International

Explore further: Combining epilepsy drug, morphine can result in less pain, lower opioid doses

add to favorites email to friend print save as pdf

Related Stories

Europe's new age of metals begins

53 minutes ago

ESA has joined forces with other leading research institutions and more than 180 European companies in a billion-euro effort developing new types of metals and manufacturing techniques for this century.

Recommended for you

Vaccine proves effective against deadly Middle East virus

22 hours ago

(Medical Xpress)—A vaccine developed by an international team of scientists led by the University of Pittsburgh School of Medicine successfully protects mice against a contagious and deadly virus spreading across the Middle ...

New study looks at improving vaccine awareness

23 hours ago

The best medical therapies won't do much good if the public abstains from using them. Resistance to life-saving interventions may have a variety of root causes, particularly if the biotechnology involved is new and poorly ...

High-dose opioid prescribing continues to climb

Sep 12, 2014

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new ...

Feds say Bayer colon supplement makes bogus claims

Sep 12, 2014

The United States government accused Bayer of making scientifically unproven statements about the health benefits of a popular probiotic on Friday, claiming the German pharmaceutical giant was in contempt of court.

User comments : 0